- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05930717
Zhejiang Nutrition and Health Study (NuLife)
August 25, 2023 updated by: Jusheng Zheng, Westlake University
Zhejiang Nutrition and Health Study: Nutrition and Lifespan Study (NuLife Study)
This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province.
The cohort will include individuals in a wide range of age groups.
The demographic, diet, lifestyle information, health status, and corresponding bio-samples will be collected carefully.
It will give a deeper insight to the relation between nutrition and healthy aging and longevity.
Ultimately, this research will contribute to evidence-based nutrition interventions to improve health outcomes and enhance quality of life.
Study Overview
Status
Recruiting
Detailed Description
This project aims to elucidate the relationship between healthy lifespan and nutrition through the establishment of a large-scale cohort of participants and longitudinal follow-ups spanning around 10 years in Zhejiang Province.
The cohort will comprise individuals in a wide range of age groups starting at 6 years old.
The participants will provide demographic information, anthropometry measurements, detailed diet, lifestyle data and health status, including 3-day dietary records and long-term food intake frequency recalls.
Integrated with previous information, diverse bio-samples will also be collected to establish a multi-dimensional biobank.
It will give a deeper insight to the relation between nutrition and healthy aging and longevity.
Ultimately, this research will contribute to the development of evidence-based nutrition designed to improve health outcomes and enhance the quality of life for individuals of all ages.
Study Type
Observational
Enrollment (Estimated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ke Zhang, Bachelor
- Phone Number: 86-18888641943
- Email: zhangke@westlake.edu.cn
Study Contact Backup
- Name: Wanglong Gou, PhD
- Phone Number: 86-13819107649
- Email: gouwanglong@westlake.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310052
- Recruiting
- Zhejiang Provincial Center for Disease Control and Prevention
-
Contact:
- Danting Su, Master
- Phone Number: 86-0571-87115262
- Email: dtsu@cdc.zj.cn
-
Contact:
- Dan Han, Master
- Phone Number: 86-0571-87115324
- Email: dhan@cdc.zj.cn
-
Principal Investigator:
- Ronghua Zhang, Master
-
Hangzhou, Zhejiang, China
- Recruiting
- Westlake University
-
Contact:
- Ke Zhang, Bachelor
- Phone Number: 86-18888641943
- Email: zhangke@westlake.edu.cn
-
Principal Investigator:
- Ju-Sheng Zheng, PhD
-
Contact:
- Wanglong Gou, PhD
- Phone Number: 86-13819107649
- Email: gouwanglong@westlake.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Permanent residents in Zhejiang Province
Description
Inclusion Criteria:
- Chinese citizens who have resided in the surveyed area for at least 6 months before the survey within the last 12 months.
- Aged 6 years or older.
- They are included as resident households, which are comprised of people living together in one place based on family relationships, and at least one resident with permanent household registration.
Exclusion Criteria:
- Residents living in functional zones such as construction worker dormitories, military barracks, schools, nursing homes, etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of cardio-metabolic diseases
Time Frame: up to 10 years
|
The investigators will track for occurrence of cardio-metabolic diseases by follow-up surveys collected by the Zhejiang Center for Disease Control and Prevention.
|
up to 10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in fasting blood glucose
Time Frame: Every other year, up to 10 years
|
Fasting glucose will be examined in mmol/L.
|
Every other year, up to 10 years
|
Changes in fasting blood HbA1c
Time Frame: Every other year, up to 10 years
|
Fasting blood HbA1c will be examined in %
|
Every other year, up to 10 years
|
Changes in fasting lipid metabolism
Time Frame: Every other year, up to 10 years
|
Triglyceride, cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol will be examined in mmol/L.
|
Every other year, up to 10 years
|
Changes in fasting blood highly sensitive C-reactive protein (CRP)
Time Frame: Every other year, up to 10 years
|
CRP will be examined in mg/L.
|
Every other year, up to 10 years
|
Changes in body mass index
Time Frame: Every other year, up to 10 years
|
Body mass index (BMI) will be calculated in kg/m^2
|
Every other year, up to 10 years
|
Changes in blood pressure
Time Frame: Every other year, up to 10 years
|
Blood pressure, including systolic and diastolic blood pressure, will be measured in mmHg
|
Every other year, up to 10 years
|
Changes in gut microbiome profiling
Time Frame: Every other year, up to 10 years
|
16S rRNA and/or shotgun metagenomic sequencing will be performed in stool samples.
|
Every other year, up to 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ju-Sheng Zheng, PhD, Westlake University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 19, 2023
Primary Completion (Estimated)
July 1, 2033
Study Completion (Estimated)
July 1, 2033
Study Registration Dates
First Submitted
June 26, 2023
First Submitted That Met QC Criteria
July 3, 2023
First Posted (Actual)
July 5, 2023
Study Record Updates
Last Update Posted (Actual)
August 29, 2023
Last Update Submitted That Met QC Criteria
August 25, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20230511JZS001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States